Reports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016
RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September 30, 2016.
Third Quarter Highlights
- Net revenues of $64.2 million for the third quarter
- GAAP net income of $3.9 million, or $0.08 per diluted share for the third quarter
- Adjusted non-GAAP net income of $6.6 million, or $0.14 per diluted share for the third quarter
Dr. Jack Zhang, Amphastar’s CEO, commented: “We are pleased with the Company’s profitability for the quarter and look forward to potential product approvals in the coming months.”